Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 7

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 14

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 21

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 28

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 35

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 42

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 49

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 56

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 63

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 70

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 77

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 84

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 91

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 98

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 105

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 112

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 119

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 126

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 133

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 140

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 147

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 154

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 161

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 168

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 175

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 182

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 189

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 196

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 203

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 210

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 217

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 223

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php on line 228

Deprecated: Function create_function() is deprecated in /var/www/wp-content/themes/Newspaper/functions.php on line 68

Warning: Cannot modify header information - headers already sent by (output started at /var/www/wp-content/themes/Newspaper/includes/widgets/td_page_builder_widgets.php:161) in /var/www/wp-includes/feed-rss2.php on line 8
Pre Workout – Redcon1 Online Official https://redcon1online.com The Highest State of Readiness Wed, 02 Aug 2017 15:27:49 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 The Forgotten Vitamin K https://redcon1online.com/vitamin-k/ Fri, 04 Aug 2017 04:00:42 +0000 https://redcon1online.com/?p=4378 With pre-workouts and amino acid products flooding the market, the basic health supplements sadly take a back seat. Don’t get me wrong, ergogenic aids like pre workouts and amino acid products are heavily stocked on my supplement shelf because those are the products that will directly help you build muscle and lose body fat, but what about indirectly? If you’re not functioning and operating at 100%, why would your body spend valuable energy and resources to build muscle? Your body only cares about survival, not how lean you are or how much muscle you can hold on your frame…this is where health supplements like the forgotten vitamin k come into play!

Vitamin K is an essential vitamin that is one of the four fat-soluble vitamins. Vitamin K comes in different forms (vitamers) that are either phylloquinones (vitamin K1) or menaquinones (vitamin K2 which is abbreviated as MK-x.) The three forms of vitamin K that can be utilized by the body are vitamin K1 and dual forms of K2 (MK-4 and MK-7.) The health benefits of vitamin k seem endless and include regression of preformed arterial calcification, maintenance of bone density, and promotion of a healthy heart and vascular system. As with all of my articles, I do not feel making claims on a product or ingredient is good enough. Instead, we must dig into the research…and luckily for us. vitamin k has well over 400 studies that I have personally read over the years. The first one I wish to look at is from Knapen et al and looked at a three-year low-dose menaquinone-7 supplementation and how it helps decrease bone loss. The results were that MK-7 intake significantly improved vitamin K status and decreased the age-related decline in BMC and BMD at the lumbar spine and femoral neck, but not at the total hip. Bone strength was also favorably affected by MK-7. MK-7 significantly decreased the loss in vertebral height of the lower thoracic region at the mid-site of the vertebrae. This lead to their conclusion that MK-7 supplements may help  to prevent bone loss (1.)

But even more importantly that aiding in bone mineral density is its ability to fight atherosclerosis (as this is my main reason for recommending this vitamin to bodybuilders that are using potentially harsh supplements that can cause atherosclerosis over time.) Jennifer Ming has talked extensively on this topic stating that “numerous studies have demonstrated that people with higher intakes of vitamin K2 have a reduced risk for cardiovascular disease.  Intrigued by this connection, Polish researchers from the Medical University at Lodz teamed up with researchers from Maastricht University in the Netherlands and Poland’s International Science and Health Foundation to determine if vitamin K2 supplementation could reduce the progression of existing atherosclerosis. The scientists evaluated the progression of atherosclerosis in a group of 42 patients with chronic kidney disease. These patients were ideal for this type of study because they are known to experience a rapid reduction in bone mineral density (a measure of bone strength) as a result of calcium losses from bone. They are also subject to equally excessive deposits of calcium in tissues where it doesn’t belong—particularly in the walls of major arteries. For the study, the subjects were divided into two groups. One group received vitamin K2 (90 mcg per day) plus vitamin D3 (400 IU per day). The second group received only vitamin D3 (400 IU per day). After nine months, it was already evident that the subjects taking the combination of vitamins K2 and D3 experienced a slower progression of the Common Carotid Intima Media Thickness, which is a good indicator of atherosclerosis, as well as a predictor of cardiovascular episodes and death. Specifically, the thickness of the carotid (major neck) arteries increased by 13.73% in the group taking vitamin D3, but in the group taking both vitamins, it only increased by 6.32%. Remember that the group of subjects in this study have a tendency for an increased carotid intima media thickness as a result of calcium losses from bone. In addition, subjects taking the combination of vitamins K2 and D3 showed a reduction in carotid artery calcification score in all patients except those with the highest scores at baseline. This indicates that calcium was staying in the bones, where it belongs, and out of the arteries. These results clearly indicated that vitamin K2 does indeed reduce the progression of atherosclerosis” (2, 3, 4.)

Vitamin K clearly has a place on everyone’s health supplement shelf and has more than enough literature and actual application to back that statement up. In terms of practical application, we need to look at a few different minimum effective dosages for the various forms of vitamin k. For phylloquinone (vitamin K1), the minimum effective dosage is 50mcgs. For short chain menaquinones (MK-4), the minimum effective dosage is 1500mcgs. For the longer chain menaquinones (MK-7, MK-8, and MK-9), the minimum effective dose is around 100-250mcgs. So be sure to purchase a vitamin k product that contains the effective forms of vitamin k and in the proper dosages.

Alex Kikel

MS, PES, CPT, Speed and Explosion Specialist Level II

Owner of www.theprepcoach.com

References

  1. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. M. H. J. Knapen, N. E. Drummen, E. Smit, C. Vermeer, E. Theuwissen. Osteoporos Int. 2013 (https://www.ncbi.nlm.nih.gov/pubmed/23525894)
  2. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. Johanna M. Geleijnse, Cees Vermeer, Diederick E. Grobbee, Leon J. Schurgers, Marjo H. J. Knapen, Irene M. van der Meer, Albert Hofman, Jacqueline C. M. Witteman. J Nutr. 2004 (https://www.ncbi.nlm.nih.gov/pubmed/15514282)
  3. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. Ilona Kurnatowska, Piotr Grzelak, Anna Masajtis-Zagajewska, Magdalena Kaczmarska, Ludomir Stefańczyk, Cees Vermeer, Katarzyna Maresz, Michał Nowicki. Pol Arch Med Wewn. 2015 (https://www.ncbi.nlm.nih.gov/pubmed/26176325)
  4. Is Coronary Artery Calcification Associated with Vertebral Bone Density in Nondialyzed Chronic Kidney Disease Patients? Filgueira, A., Carvalho, A. B., Tomiyama, C., Higa, A., Rochitte, C. E., Santos, R. D., & Canziani, M. E. F. (2011). Clinical Journal of the American Society of Nephrology. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109944/)
]]>
Is Beta Alanine In YOUR Preworkout?! https://redcon1online.com/beta-alanine-preworkout/ Mon, 24 Jul 2017 17:11:05 +0000 https://redcon1online.com/?p=4320 Beta Alanine is an ingredient that is very popular in the supplement community but really isn’t discussed very much (and sadly usually isn’t dosed properly in many formulas on the market.) I think you should not only know what beta alanine is but also what it does, why you want it, and which products actually have clinical dosages (or proper dosages for lack of a better term.) Beta-alanine, the building block of carnosine, helps buffer acid in muscles and increases physical performance in the 60–240-second range. When beta-alanine is ingested, it turns into carnosine, which acts as that acid buffer. Carnosine is stored in cells and released in response to drops in pH. Paresthesia, the tingling feeling, can be caused by bigger dosages of beta alanine but it is simply a harmless side effect that usually disappears with usage. Beta Alanine has been shown to aid in increasing power, endurance, and reducing time to fatigue (along with a number of other benefits.)

Increased power output from muscle carnosine was shown by one of the more popular studies from Baguet et al in rowing performance. Chronic oral β-alanine supplementation is shown to elevate muscle carnosine content and improve anaerobic exercise performance during some laboratory tests, mainly in the untrained. It remains to be determined whether carnosine loading can improve single competition-like events in elite athletes. The aims of the present study were to investigate if performance is related to the muscle carnosine content and if β-alanine supplementation improves performance in highly trained rowers. Eighteen Belgian elite rowers were supplemented for 7 wk with either placebo or β-alanine (5 g/day). Before and following supplementation, muscle carnosine content in soleus and gastrocnemius medialis was measured by proton magnetic resonance spectroscopy ((1)H-MRS) and the performance was evaluated in a 2,000-m ergometer test. At baseline, there was a strong positive correlation between 100-, 500-, 2,000-, and 6,000-m speed and muscle carnosine content. After β-alanine supplementation, the carnosine content increased by 45.3% in soleus and 28.2% in gastrocnemius. Following supplementation, the β-alanine group was 4.3 s faster than the placebo group, whereas before supplementation they were 0.3 s slower (P = 0.07). Muscle carnosine elevation was positively correlated to 2,000-m performance enhancement (P = 0.042 and r = 0.498). It can be concluded that the positive correlation between baseline muscle carnosine levels and rowing performance and the positive correlation between changes in muscle carnosine and performance improvement suggest that muscle carnosine is a new determinant of rowing performance (1.)

Hobson et al conducted a very important bit of literature on beta alanine supplementation and its direct effects on exercise performance in a meta analysis. They stated that “due to the well-defined role of β-alanine as a substrate of carnosine (a major contributor to H+ buffering during high-intensity exercise), β-alanine is fast becoming a popular ergogenic aid to sports performance. There have been several recent qualitative review articles published on the topic, and here we present a preliminary quantitative review of the literature through a meta-analysis. A comprehensive search of the literature was employed to identify all studies suitable for inclusion in the analysis; strict exclusion criteria were also applied. Fifteen published manuscripts were included in the analysis, which reported the results of 57 measures within 23 exercise tests, using 18 supplementation regimes and a total of 360 participants [174, β-alanine supplementation group (BA) and 186, placebo supplementation group (Pla)]. BA improved (P=0.002) the outcome of exercise measures to a greater extent than Pla [median effect size (IQR): BA 0.374 (0.140-0.747), Pla 0.108 (-0.019 to 0.487)]. Some of that effect might be explained by the improvement (P=0.013) in exercise capacity with BA compared to Pla; no improvement was seen for exercise performance (P=0.204). In line with the purported mechanisms for an ergogenic effect of β-alanine supplementation, exercise lasting 60-240 s was improved (P=0.001) in BA compared to Pla, as was exercise of >240 s (P=0.046). In contrast, there was no benefit of β-alanine on exercise lasting <60 s (P=0.312). The median effect of β-alanine supplementation is a 2.85% (-0.37 to 10.49%) improvement in the outcome of an exercise measure, when a median total of 179 g of β-alanine is supplemented” (2.)

Finally, we’ll conclude on its ability to reduce fatigue from the works of Hoffman et al. The purpose of this study was to examine the effect of 30 days of beta-alanine supplementation in collegiate football players on anaerobic performance measures. Subjects were randomly divided into a supplement (beta-alanine group [BA], 4.5 g x d(-1) of beta-alanine) or placebo (placebo group [P], 4.5 g x d(-1) of maltodextrin) group. Supplementation began 3 weeks before preseason football training camp and continued for an additional 9 days during camp. Performance measures included a 60-second Wingate anaerobic power test and 3 line drills (200-yd shuttle runs with a 2-minute rest between sprints) assessed on day 1 of training camp. Training logs recorded resistance training volumes, and subjects completed questionnaires on subjective feelings of soreness, fatigue, and practice intensity. No difference was seen in fatigue rate in the line drill, but a trend (P = .07) was observed for a lower fatigue rate for BA compared with P during the Wingate anaerobic power test. A significantly higher training volume was seen for BA in the bench press exercise, and a trend (P = .09) for a greater training volume was seen for all resistance exercise sessions. In addition, subjective feelings of fatigue were significantly lower for BA than P. In conclusion, despite a trend toward lower fatigue rates during 60 seconds of maximal exercise, 3 weeks of beta-alanine supplementation did not result in significant improvements in fatigue rates during high-intensity anaerobic exercise. However, higher training volumes and lower subjective feelings of fatigue in BA indicated that as duration of supplementation continued, the efficacy of beta-alanine supplementation in highly trained athletes became apparent (3.)

It is clear that beta alanine is a supplement that is beyond beneficial for any athletic endeavor! In these studies, we see a wide array of dosages from 2 grams all the way up to 5 grams. It has been concluded that 3.2 grams of beta alanine is the accepted clinical dosage. If your taking a pre workout that has LESS than that clinical amount then you’re pretty much wasting your money as you will not reap the full benefits. Luckily, supplements like Total War from RedCon1 provide the full 3.2 gram clinical dosage of beta alanine along with other great ergogenic aids like citrulline malate, agmatine sulfate, and a number of others ALL having the correct clinical dosage.

Alex Kikel

MS, PES, CPT, Speed and Explosion Specialist Level II

Owner of www.theprepcoach.com

References

  1. Important role of muscle carnosine in rowing performance. Audrey Baguet, Jan Bourgois, Lander Vanhee, Eric Achten, Wim Derave. J Appl Physiol (1985) 2010 (https://www.ncbi.nlm.nih.gov/pubmed/20671038)
  2. Effects of β-alanine supplementation on exercise performance: a meta-analysis. R. M. Hobson, B. Saunders, G. Ball, R. C. Harris, C. Sale. Amino Acids. 2012 (https://www.ncbi.nlm.nih.gov/pubmed/22270875)
  3. Short-duration beta-alanine supplementation increases training volume and reduces subjective feelings of fatigue in college football players. Jay R. Hoffman, Nicholas A. Ratamess, Avery D. Faigenbaum, Ryan Ross, Jie Kang, Jeffrey R. Stout, John A. Wise. Nutr Res. 2008 (https://www.ncbi.nlm.nih.gov/pubmed/19083385)
]]>
Exercise Your Demons https://redcon1online.com/exercise-your-demons/ Tue, 18 Jul 2017 18:05:47 +0000 https://redcon1online.com/?p=4247 You would be hard pressed to find a more polarizing binary than the relationship society has with bodybuilding’s less-than-secretive marinade, “the sauce.” Anabolic-androgenic steroids have been a topic of controversial relevancy since their international debut via a cosmonaut air drop of Turinabol to Russian athletes in 1962. The introduction of these novel compounds stirred a literal arms race that prompted the research and development of hundreds of functional hormone derivatives, which have been the plight of anti-doping agencies for decades. As of recent, advances in drug detection technology have revealed what most already knew… athletes of every discipline and caliber are juiced up like a bottle of Florida Orange. Progression, however, is an intuitive component of human biology. The constant compulsion to improve has been the greatest catalyst of this species’ development – best exemplified by the universal practice of competitive sports over its evolutionary course. 

Admiration. Fear. Disgust. Such terms often accompany an egregiously muscular physique. For better, or for worse, the general public remains enamored at the sight of a sidewalk cracking specimen despite any moral or aesthetic reservations they may carry. The need to even reference “morals” only exists due to the persistent demonizing of steroid use commonly associated with bodybuilders. More often than not the sheep of society will discredit a well-developed physique as nothing more than fictitious mass inflated by chronic drug abuse. These rampant displays of ignorance are a significant contributing factor for the sport’s inability to garner societal acceptance and financial interest from more conventional corporate contributors. A near-sighted perspective when considering that their absence places an inhibition on further athletic advancement beyond its current limitations. The policy in and of itself is contradictory to the very heart of competition. Competitors – true competitors, not mere participants – aspire to reach new tiers of human physical performance and despite many wasted pennies at the wishing-well, the viability of X-Men style genetic mutations is beginning to look bleak. If mainstream audiences continue to expect furthering degrees of superhuman abilities then they must come to understand the need for a superhuman physiology. 

It is hardly news worthy to comment that PEDs(Performance Enhancing Drugs) exist at the upper echelon of nearly every competitive activity known. Yet, the populace is dumbfounded upon discovering that their favorite athletic icon has been dabbling in “extracurricular” supplementation between batting practice. Bodybuilding’s double-edged sword is its lack of subtlety regarding the more illicit elements that accompany it. Bombastic displays of freakish mass do little to quell steroid accusations, which, in truth, are usually correct. Consequently, bodybuilding is self-defeating by nature and continually fails to infiltrate sports programming networks or any significant level of mainstream exposure. Although Kai Greene has seen some success outside of wearing posing trunks, his reach is still quite limited when compared to the charismatic career of Arnold, who’s classic lines were befitting of Hollywood.

Despite the bastardization that stems from its use, steroids are more often than not referred to with a positive connotation in present day culture. Simply attach “on steroids” to the end of a noun and it instantly resonates a complimentary tone. Although the concept of needle-based drug usage will remain taboo around the dinner table, the popularity of PEDs within the fitness industry is higher than Snoop Dogg could ever hope to be. Ever since the Archduke of Anadrol, Bostin Loyd, expunged the extreme nature of bodybuilding culture, online forums have essentially transitioned into a pissing contest of Tren and Superdrol. This poses a quandary of a question: take the plunger and get country big or stand around in an extra schmedium tank top while wearing your D.A.R.E. sticker from middle school? Fortunately you do not need to compromise your childhood ethics in order to obtain a God-bod. For all their physically potentiating prowess, the novelty of risqué ‘roid usage wears faster than vital health markers. 

Satire aside, there are notable anabolic alternatives presently available on the market. DHEA based prohormones have seen a surge in popularity since DASCA all but razed grey-area designers entirely. Traditionally, DHEA compounds have been overlooked due to being far less cost effective than their more readily active counterparts. Supplement industry innovator, Redcon1, however, has released a well-rounded line of these prohormones that afford the modern iron monger supraphysiological gains without supraphysiological side-effects. By introducing an ingenious Liposomal delivery system into its formulation, Redcon1’s SOMAL products are capable of achieving a standard of bioavailability nearing one-hundred percent. This exceptionally high conversion rate into the target compound allows users to experience the benefits of exogenous hormone usage without compromising the monthly food budget. Those who desire sheer mass and aggression would be wise to sample the tantalizing taste of SOMAL-4’s final form, Testosterone. As the predominant male hormone, no other compound shares its muscle potentiating effects. Alternatively, individuals who prefer less dramatic, leaner mass gains should reference SOMAL-1. Although a structural derivative of Testosterone, the introduction of 1-Testosterone via SOMAL-1 does not raise estradiol or impart a sudden spike in weight gain to the degree that Testosterone does. Rather, it exhibits a high binding affinity for androgen receptors that grant it superior strength enhancing properties, which makes its use advantageous in both bulking and cutting applications.

Rest assured, these two-stepping precursors meet all legal compliances despite their renowned effects on strength and mass acquisition. Lunge your way over to Redcon1.com, or download the app, to learn how SOMAL-1 and SOMAL-4 will allow you to reach your highest state of readiness.

]]>
Sulforaphane to Inhibit Myostatin? 3 https://redcon1online.com/sulforaphane-inhibit-myostatin-3/ Sat, 24 Jun 2017 16:29:22 +0000 https://redcon1online.com/?p=4055 In closing, lets bring in its ability to act as a significant anti-inflammatory and anti-cancer agent. I would like to look at three pieces of literature. The first is on the inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors by Bali et al. The second is on  histone deacetylase inhibitors: signalling towards p21cip1/waf1 from Matthias Ocker. The third and final is entitled “A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase” from Myzak et al. The hydroxamic acid (HAA) analogue pan-histone deacetylase (HDAC) inhibitors (HDIs) LAQ824 and LBH589 have been shown to induce acetylation and inhibit the ATP binding and chaperone function of heat shock protein (HSP) 90. This promotes the polyubiquitylation and degradation of the pro-growth and pro-survival client proteins Bcr-Abl, mutant FLT-3, c-Raf, and AKT in human leukemia cells. HDAC6 is a member of the class IIB HDACs. It is predominantly cytosolic, microtubule-associated alpha-tubulin deacetylase that is also known to promote aggresome inclusion of the misfolded polyubiquitylated proteins. Here we demonstrate that in the Bcr-abl oncogene expressing human leukemia K562 cells, HDAC6 can be co-immunoprecipitated with HSP90, and the knock-down of HDAC6 by its siRNA induced the acetylation of HSP90 and alpha-tubulin. Depletion of HDAC6 levels also inhibited the binding of HSP90 to ATP, reduced the chaperone association of HSP90 with its client proteins, e.g. Bcr-Abl, and induced polyubiquitylation and partial depletion of Bcr-Abl. Conversely, the ectopic overexpression of HDAC6 inhibited LAQ824-induced acetylation of HSP90 and alpha-tubulin and reduced LAQ824-mediated depletion of Bcr-Abl, AKT, and c-Raf. Collectively, these findings indicate that HDAC6 is also an HSP90 deacetylase. Targeted inhibition of HDAC6 leads to acetylation of HSP90 and disruption of its chaperone function, resulting in polyubiquitylation and depletion of pro-growth and pro-survival HSP90 client proteins including Bcr-Abl. Depletion of HDAC6 sensitized human leukemia cells to HAA-HDIs and proteasome inhibitors (9.) Chromatin-modifying enzymes such as histone deacetylases (HDAC) facilitate a closed chromatin structure and hence transcriptional repression. HDAC are commonly affected in human cancer diseases. Thus, inhibition of HDAC represents a novel therapeutic approach. Several studies have shown that HDAC inhibitors strongly activate the expression of the cyclin-dependent kinase inhibitor p21(cip1/waf1) through (i) enhanced histone acetylation around the p21(cip1/waf1) promoter and (ii) the Sp1 sites on the p21(cip1/waf1) promoter releasing the repressor HDAC1 from its binding. p21(cip1/waf1) expression is regulated in a p53-dependent and p53-independent manner. The decision if p21(cip1/waf1) up-regulation results in cell cycle arrest or apoptosis, decides about the therapeutic efficacy of an anti-cancer treatment with HDAC inhibitors (10.) Sulforaphane (SFN), a compound found at high levels in broccoli and broccoli sprouts, is a potent inducer of phase 2 detoxification enzymes and inhibits tumorigenesis in animal models. SFN also has a marked effect on cell cycle checkpoint controls and cell survival and/or apoptosis in various cancer cells, through mechanisms that are poorly understood. We tested the hypothesis that SFN acts as an inhibitor of histone deacetylase (HDAC). In human embryonic kidney 293 cells, SFN dose-dependently increased the activity of a beta-catenin-responsive reporter (TOPflash), without altering beta-catenin or HDAC protein levels. Cytoplasmic and nuclear extracts from these cells had diminished HDAC activity, and both global and localized histone acetylation was increased, compared with untreated controls. Studies with SFN and with media from SFN-treated cells indicated that the parent compound was not responsible for the inhibition of HDAC, and this was confirmed using an inhibitor of glutathione S-transferase, which blocked the first step in the metabolism of SFN, via the mercapturic acid pathway. Whereas SFN and its glutathione conjugate (SFN-GSH) had little or no effect, the two major metabolites SFN-cysteine and SFN-N-acetylcysteine were effective HDAC inhibitors in vitro. Finally, several of these findings were recapitulated in HCT116 human colorectal cancer cells: SFN dose-dependently increased TOPflash reporter activity and inhibited HDAC activity, there was an increase in acetylated histones and in p21(Cip1/Waf1), and chromatin immunoprecipitation assays revealed an increase in acetylated histones bound to the P21 promoter. Collectively, these findings suggest that SFN may be effective as a tumor-suppressing agent and as a chemotherapeutic agent, alone or in combination with other HDAC inhibitors currently undergoing clinical trials (11.)

Sulforaphane’s ability to do everything we just discussed should make you want to start eating your broccoli as well as possibly supplementing with a good sulforaphane product (which is very few and fair between.) In terms of an applicable dosage, it seems that right around the 30mg per day mark is proven in literature to be beneficial (with some even dosing it up to double based on their body weight being higher.) Sulforaphane’s benefits are endless and is a must have health AND ergogenic aid supplement for any serious competitor (or at least it is in my eyes.)

References

  1. Protein oxidation and aging. E. R. Stadtman. Science. 1992 (https://www.ncbi.nlm.nih.gov/pubmed/1355616)
  2. Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27. Nanqin Gan, Yu-Chieh Wu, Mathilde Brunet, Carmen Garrido, Fung-Lung Chung, Chengkai Dai, Lixin Mi. J Biol Chem. 2010 (https://www.ncbi.nlm.nih.gov/pubmed/20833711)
  3. Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Mi-Kyoung Kwak, Jeong-Min Cho, Bo Huang, Soona Shin, Thomas W. Kensler. Free Radic Biol Med. 2007 (https://www.ncbi.nlm.nih.gov/pubmed/17664144)
  4. Sulforaphane induced adipolysis via hormone sensitive lipase activation, regulated by AMPK signaling pathway. Ju-Hee Lee, Myung-Hee Moon, Jae-Kyo Jeong, Yang-Gyu Park, You-Jin Lee, Jae-Won Seol, Sang-Youel Park. Biochem Biophys Res Commun. 2012 (https://www.ncbi.nlm.nih.gov/pubmed/22982310)
  5. Identification and role of the basal phosphorylation site on hormone-sensitive lipase. A. J. Garton, S. J. Yeaman. Eur J Biochem. 1990 (https://www.ncbi.nlm.nih.gov/pubmed/2165906)
  6. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. Mandeep Pinky Gaidhu, Sergiu Fediuc, Rolando Bacis Ceddia. J Biol Chem. 2006 (https://www.ncbi.nlm.nih.gov/pubmed/16816404)
  7. Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells. Huitao Fan, Rui Zhang, Dawit Tesfaye, Ernst Tholen, Christian Looft, Michael Hölker, Karl Schellander, Mehmet Ulas Cinar. Epigenetics. 2012 (https://www.ncbi.nlm.nih.gov/pubmed/23092945)
  8. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Chang Joo Oh, Joon-Young Kim, Ae-Kyung Min, Keun-Gyu Park, Robert A. Harris, Han-Jong Kim, In-Kyu Lee. Free Radic Biol Med. 2012 (https://www.ncbi.nlm.nih.gov/pubmed/22155056)
  9. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. Purva Bali, Michael Pranpat, James Bradner, Maria Balasis, Warren Fiskus, Fei Guo, Kathy Rocha, Sandhya Kumaraswamy, Sandhya Boyapalle, Peter Atadja, et al. J Biol Chem. 2005 (https://www.ncbi.nlm.nih.gov/pubmed/15937340)
  10. Histone deacetylase inhibitors: signalling towards p21cip1/waf1. Matthias Ocker, Regine Schneider-Stock. Int J Biochem Cell Biol. 2007 (https://www.ncbi.nlm.nih.gov/pubmed/17412634)
  11. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Melinda C. Myzak, P. Andrew Karplus, Fung-Lung Chung, Roderick H. Dashwood. Cancer Res. 2004 (https://www.ncbi.nlm.nih.gov/pubmed/15313918)
]]>
Why You Might Not Be Growing Part 2 https://redcon1online.com/not-growing-2/ Wed, 21 Jun 2017 04:00:58 +0000 https://redcon1online.com/?p=3995 Participants completed the visual analog scales for global vigor and global affect at 2-hour intervals each day. Comparisons between conditions were performed using 2-sided nonparametric Wilcoxon tests with a significance level of .05. The 10 healthy men had a mean (SD) age of 24.3 (4.3) years and a mean (SD) body mass index of 23.5 (2.4) (calculated as weight in kilograms divided by height in meters squared). Total (SD) sleep time decreased from 8 hours 55 minutes (35 min) to 4 hours 48 minutes (6 min) with sleep restriction (P = .002). Relative to the rested condition, during each restricted night, participants lost a total (SD) of 2 hours 45 minutes (29 min) of stage-2 sleep (P = .002) and 1 hour 3 minutes (18 min) of REM sleep (P = .002) and gained 9 minutes (8 min) of sleep in stages 3 + 4 (P = .01). During waking hours common to both conditions (8 AM-10 PM), testosterone levels were lower after sleep restriction than in the rested condition (16.5 [2.8] nmol/L vs 18.4 [3.8] nmol/L; P = .049). The effect of restricted sleep was especially apparent between 2 PM and 10 PM (15.5 [3.1] nmol/L vs 17.9 [4.0] nmol/L; P = .02). Daytime cortisol profiles were similar under both conditions. Daily sleep restriction was associated with a progressive decrease in mean (SD) vigor scores from 28 (5) after the first night to 19 (7) after the seventh night (P = .002).  Shown are mean values. In the rested condition, bedtimes were from 10 PM to 8 AM. Values for partial sleep restriction were taken after 1 week of restriction, for which bedtimes were from 12:30 AM to 5:30 AM. On average over the 68 time points, the SD of testosterone levels at each time point was 5.01 nmol/L (range, 2.98-7.53 nmol/L) in the rested condition and 4.26 nmol/L (range, 2.82-6.92 nmol/L) in the restricted condition. On average over the 68 time points, the SD of cortisol levels at each time point was 67.1 nmol/L (range, 15.2-142.7 nmol/L) in the rested condition and 54.0 nmol/L (range, 7.7-162.3 nmol/L) in the restricted condition (2.)

In close relation is a study on sleep deprivation and how it reduces circulating androgens in healthy men. “The acute effect of sleep deprivation on the pituitary-testis axis was evaluated in 13 healthy men. To study such association, the circulating levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), Androstenedione (A), Testosterone (T), Dihydro-testosterone (DHT) and Estradiol (E2) were measured along with Cortisol (C) before and after sleep deprivation. Morning (8:00 AM) venous blood samples were obtained prior and after a continuous restless period of 24 hr and the values were analyzed by the paired Student’s t test. There was a significant and parallel decrease of each androgen and E2 but not of FSH, L.H. PRL, or C, associated with the acute sleep deprivation” (3.) The issues that we are seeing tie directly into cortisol. The issue that arises is that coristol usually pulsates in pattern (meaning its higher in the morning and lower at night) BUT when sleep is deprived, it essentially disrupts this pattern and there by increases serum cortisol levels. Leproult shows this very well in a study from 1997. Sleep curtailment constitutes an increasingly common condition in industrialized societies and is thought to affect mood and performance rather than physiological functions. There is no evidence for prolonged or delayed effects of sleep loss on the hypothalamo-pituitary-adrenal (HPA) axis. We evaluated the effects of acute partial or total sleep deprivation on the nighttime and daytime profile of cortisol levels. Plasma cortisol profiles were determined during a 32-hour period (from 1800 hours on day 1 until 0200 hours on day 3) in normal young men submitted to three different protocols: normal sleep schedule (2300-0700 hours), partial sleep deprivation (0400-0800 hours), and total sleep deprivation. Alterations in cortisol levels could only be demonstrated in the evening following the night of sleep deprivation. After normal sleep, plasma cortisol levels over the 1800-2300-hour period were similar on days 1 and 2. After partial and total sleep deprivation, plasma cortisol levels over the 1800-2300-hour period were higher on day 2 than on day 1 (37 and 45% increases, p = 0.03 and 0.003, respectively), and the onset of the quiescent period of cortisol secretion was delayed by at least 1 hour. We conclude that even partial acute sleep loss delays the recovery of the HPA from early morning circadian stimulation and is thus likely to involve an alteration in negative glucocorticoid feedback regulation. Sleep loss could thus affect the resiliency of the stress response and may accelerate the development of metabolic and cognitive consequences of glucocorticoid excess (4.)

References

  1. Acute partial sleep deprivation increases food intake in healthy men. Laurent Brondel, Michael A. Romer, Pauline M. Nougues, Peio Touyarou, Damien Davenne. Am J Clin Nutr. 2010 (https://www.ncbi.nlm.nih.gov/pubmed/20357041)
  2. Effect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy Men. Leproult, R., & Van Cauter, E. (2011). (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445839/)
  3. Sleep deprivation reduces circulating androgens in healthy men. V. Cortés-Gallegos, G. Castañeda, R. Alonso, I. Sojo, A. Carranco, C. Cervantes, A. Parra. Arch Androl. 1983 (https://www.ncbi.nlm.nih.gov/pubmed/6405703)
  4. Sleep loss results in an elevation of cortisol levels the next evening. R. Leproult, G. Copinschi, O. Buxton, E. Van Cauter. Sleep. 1997 (https://www.ncbi.nlm.nih.gov/pubmed/9415946)
  5. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Jutta Backhaus, Klaus Junghanns, Fritz Hohagen. Psychoneuroendocrinology. 2004 (https://www.ncbi.nlm.nih.gov/pubmed/15219642)
  6. Growth hormone secretion during sleep. Y. Takahashi, D. M. Kipnis, W. H. Daughaday. J Clin Invest. 1968 (https://www.ncbi.nlm.nih.gov/pubmed/5675428)
  7. Effect of sleep deprivation on overall 24 h growth-hormone secretion. G. Brandenberger, C. Gronfier, F. Chapotot, C. Simon, F. Piquard. Lancet. 2000 (https://www.ncbi.nlm.nih.gov/pubmed/11052586)
  8. Influence of partial sleep deprivation on energy balance and insulin sensitivity in healthy women. Anja Bosy-Westphal, Silvia Hinrichs, Kamila Jauch-Chara, Britta Hitze, Wiebke Later, Britta Wilms, Uta Settler, Achim Peters, Dieter Kiosz, Manfred James Muller. Obes Facts. 2008 (https://www.ncbi.nlm.nih.gov/pubmed/20054188)
  9. Optimism and self-esteem are related to sleep. Results from a large community-based sample. Sakari Lemola, Katri Räikkönen, Veronica Gomez, Mathias Allemand. Int J Behav Med. 2013 (https://www.ncbi.nlm.nih.gov/pubmed/23055029)
  10. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Kristen L. Knutson. Best Pract Res Clin Endocrinol Metab. (https://www.ncbi.nlm.nih.gov/pubmed/21112022)
]]>
Coaches https://redcon1online.com/coaches/ Tue, 13 Jun 2017 17:34:14 +0000 https://redcon1online.com/?p=3980 Why do we ​decide to ​stop​? ​Wh​at makes us “end” only to sometime begin again?. ​My countless beginnings have always been about the gym. I can’t count how many times I’ve “started over.” What makes each time supposedly ​”​d​​ifferent​?”​ After a 22​-​month talk​ (with my 22-month toddler)​ I started over​ again​. Weights were heavier than I remember​. Each set was harder than the last. Why is this time any different​? ​Why ​i​s starting over now go​ing​ to be the difference between then and now​? Surprise – it’s not. Starting over is starting over. But the real difference this time is ​that I genuinely want it. I want the body I know is ​there, ​underneath it all. I want to be healthy​ and happy,​ and keep up with my daughter. I want ​to​ avoid the ​​diabetes I will ​certainly have if I stay where I am. I want ​this​ for my next baby​,​ s​imply s​o ​Pregnancy 2 is far happier and healthier than Pregnancy 1. And I want it for ​Faviana, who ​watches me work – I want her to grow up knowing it’s a​n incredible​ thing to ​truly ​t​​ake care of yourself and​ develop a​ love ​for ​fitness. Motivation is what starts you and drive is what​ propels​ you ​further​. Plain and simple, this time is the same​. Starting over, like all of the times ​before​. But the difference is…I ​finally WANT it.

I also knew I couldn’t do it alone. And that​’​s OK to admit. Find yourself a good coach.

What is a good coach/mentor to you?

​To me, a good coach makes time to listen ​and communicate. I know I can expect a response in a reasonable time. ​(​No​ ​​​wait​ing anxiously for​ weeks for a reply. A good coach is one who won​’t allow you ​failure. It’s THEIR opinion you come to respect. As much as you want it for you, you want it for them​,and if you drop the ball​, you feel ​like you let two people down. Their excitement is your excitement. Their motivation is your motivation. Every​ da​y, I want to not only make myself proud​, but ​also make my coach proud. I push harder knowing​ she is there​,pushing me​. And I know as bad as I want it​,she may be the only other person that wants it more for me than I do….

The quote below is​ a long-time favorite​:

“Life’s best coaches are those who believe in you and your potential, sometimes even before you do.”

Remember this when you look for someone who is go​ing to be in charge of changing your lifestyle.

Disclaimer:​ There are ​as many good coaches as ​there are bad ones,​ so make sure you DO YOUR RESEARCH ​on the be​st fit for you. ​My perfect fit is Team Bombshell with​ Mama Bombshell, Shannon De​y​, and my personal coach​, Gennifer Strobo. You have to do what’s right for ​you, and sometimes that requires trial and error. Do not be afraid to say what you want. You pay an expert to help you so before you go and spend hard​-earned money make​sure you are willing to also invest your energy and time, and sweat. (Lots of sweat.) ​At the end of the day, YOU ​are still the one ​that must follow instructions. No one can make you get out of bed​, food prep​, or go to the gym​. But a good coach sure can make you feel accountable! No matter how you do it​ – self​-motivation or hiring help, DO IT FOR YOU!

-Wendy Capurso
@WendyLeeGovoni_Capurso
]]>
Accelerate Healing Rates Part 3 https://redcon1online.com/healing-rates-part-3/ Mon, 12 Jun 2017 04:00:52 +0000 https://redcon1online.com/?p=3931 RedCon1 – Accelerate Healing Rates Part 3

A more direct study from Xu et al looked at how TB500 accelerates overall rates of wound healing. A prokaryotic vector harboring two complete Tβ4 genes with a short linker was constructed and expressed in Escherichia coli. A pilot-scale fermentation (10 L) was performed to produce engineered bacteria and the Tβ4 dimer was purified by one-step hydrophobic interaction chromatography. The activities of the Tβ4 dimer to promote endothelial cell proliferation, migration, and sprouting were assessed by tetramethylbenzidine (methylthiazol tetrazolium), trans-well, scratch, and tube formation assays. The ability to accelerate dermal healing was assessed on rats. After fermentation, the Tβ4 dimer accounted for about 30% of all the bacteria proteins. The purity of the Tβ4 dimer reached 98% after hydrophobic interaction chromatography purification. An average of 562.4 mg/L Tβ4 dimer was acquired using a 10 L fermenter. In each assay, the dimeric Tβ4 exhibited enhanced activities compared with native Tβ4. Notably, the ability of the dimeric Tβ4 to promote cell migration was almost two times higher than that of Tβ4. The rate of dermal healing in the dimeric Tβ4-treated rats was approximately 1 day faster than with native Tβ4-treated rats. The dimeric Tβ4 exhibited enhanced activity on wound healing than native Tβ4, and the purification process was simple and cost-effective. This data could be of significant benefit for the high pain and morbidity associated with chronic wounds disease. A better strategy to develop Tβ4 as a treatment for other diseases caused by injuries such as heart attack, neurotrophic keratitis, and multiple sclerosis was also described (9.) Even further studies show its ability to further increase strength, endurance, and reduce inflammation. Sosne et al states within their abstract “Thymosin beta 4 (Tβ4) is a low molecular weight protein present in all cells except erythrocytes. Although Tβ4 is the major monomeric actin-sequestering peptide in cells and can depolymerize F-actin, evidence is mounting to support the idea that it has multiple, seemingly diverse, cellular functions. In cornea, as in other tissues, Tβ4 promotes cell migration and wound healing, has anti-inflammatory properties, and suppresses apoptosis. In this review we discuss the current state of knowledge regarding the effects of Tβ4 in maintaining the healthy, functional cornea. The clinical implications of the use of Tβ4 as a wound healing and anti-inflammatory agent are discussed.” Read more about TB500’s role in inflammation and other beneficial properties below in the reference section (10.)

In conclusion, these two peptides have a tremendous ability to help up-regulate healing rates (however their long term effectiveness and side effects have yet to be determined.) In terms of practical application, many literature and anecdotal evidence reports show that dosing BPC-157 at 1-10mcgs per kg of body weight daily and TB500 at 2mgs twice per week to be a very effective starting point. Your optimal dosage will completely be dependent on how well or how poorly you metabolize these compounds so some trial and error will be required. BPC-157 is systemic where as TB500 should be applied as close to the injured area as possible. Now go out, read more literature on these two amazing peptides, and make an informed decision for yourself as to whether or not this is something that can benefit your athletic and recovery endeavors.

References

  1. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Chung-Hsun Chang, Wen-Chung Tsai, Miao-Sui Lin, Ya-Hui Hsu, Jong-Hwei Su Pang. J Appl Physiol (1985) 2011 (https://www.ncbi.nlm.nih.gov pubmed/21030672)
  2. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation. Andrija Krivic, Tomislav Anic, Sven Seiwerth, Dubravko Huljev, Predrag Sikiric J Orthop Res. 2006 (https://www.ncbi.nlm.nih.gov/pubmed/16583442)
  3. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, Branko Turkovic, Dinko Stancic Rokotov, Luka Brcic, Marko Sever, Robert Klicek, Bozo Radic, Domagoj Drmic, et al. Curr Pharm Des. 2013 (https://www.ncbi.nlm.nih.gov/pubmed/22950504)
  4. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat. Tihomir Vuksic, Ivan Zoricic, Luka Brcic, Marko Sever, Robert Klicek, Bozo Radic, Vedran Cesarec, Lidija Berkopic, Neike Keller, Alenka Boban Blagaic, Neven Kokic, Ivan Jelic, Juraj Geber, Tomislav Anic, Sven Seiwerth, Predrag Sikiric. Surg Today. 2007 (https://www.ncbi.nlm.nih.gov/pubmed/17713731)
  5. Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. B. Keremi, Z. Lohinai, P. Komora, S. Duhaj, K. Borsi, G. Jobbagy-Ovari, K. Kallo, A. D. Szekely, A. Fazekas, C. Dobo-Nagy, P. Sikiric, G. Varga. J Physiol Pharmacol. 2009 (https://www.ncbi.nlm.nih.gov/pubmed/20388954)
  6. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Danira Pevec, Tomislav Novinscak, Luka Brcic, Kristijan Sipos, Ivana Jukic, Mario Staresinic, Sandro Mise, Iva Brcic, Danijela Kolenc, Robert Klicek, et al. Med Sci Monit. 2010 (https://www.ncbi.nlm.nih.gov/pubmed/20190676)
  7. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. B. Sebecić, V. Nikolić, P. Sikirić, S. Seiwerth, T. Sosa, L. Patrlj, Z. Grabarević, R. Rucman, M. Petek, P. Konjevoda, et al. Bone. 1999 (https://www.ncbi.nlm.nih.gov/pubmed/10071911)
  8. Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy. Chuanyu Wei, Il-Kwon Kim, Li Li, Liling Wu, Sudhiranjan Gupta. PLoS One. 2014 (https://www.ncbi.nlm.nih.gov/pubmed/25412097)
  9. A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing. Xu, T.-J., Wang, Q., Ma, X.-W., Zhang, Z., Zhang, W., Xue, X.-C., … Li, M. (2013). Drug Design, Development and Therapy. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792846/)
  10. Sosne, G., Qiu, P., & Kurpakus-Wheater, M. (2007). Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clinical Ophthalmology (Auckland, N.Z.), 1(3), 201–207. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701135)
]]>
Redcon1 Paintball! https://redcon1online.com/paintball/ Tue, 23 May 2017 18:45:00 +0000 https://redcon1online.com/?p=3747

]]>
Why Every Athlete SHOULD Use TUDCA Part 2 https://redcon1online.com/tudca-part-2/ Sun, 21 May 2017 04:00:46 +0000 https://redcon1online.com/?p=3700 Normally, athletes ingest TUDCA simply for those liver benefits it possesses, but little credit is ever given to its interactions with skeletal muscle, adipose tissue, and glucose metabolism. One of my more favorite TUDCA studies actually comes from Kars et al and looks directly at how it improves liver and muscle insulin sensitivity but does not improve adipose tissue insulin sensitivity (which is a good thing!) Insulin resistance is commonly associated with obesity. Studies conducted in obese mouse models found that endoplasmic reticulum (ER) stress contributes to insulin resistance, and treatment with tauroursodeoxycholic acid (TUDCA), a bile acid derivative that acts as a chemical chaperone to enhance protein folding and ameliorate ER stress, increases insulin sensitivity. The purpose of this study was to determine the effect of TUDCA therapy on multiorgan insulin action and metabolic factors associated with insulin resistance in obese men and women. In this study, twenty obese subjects ([means +/- SD] aged 48 +/- 11 years, BMI 37 +/- 4 kg/m2) were randomized to 4 weeks of treatment with TUDCA (1,750 mg/day) or placebo. A two-stage hyperinsulinemic-euglycemic clamp procedure in conjunction with stable isotopically labeled tracer infusions and muscle and adipose tissue biopsies were used to evaluate in vivo insulin sensitivity, cellular factors involved in insulin signaling, and cellular markers of ER stress. RESULTS Hepatic and muscle insulin sensitivity increased by approximately 30% (P < 0.05) after treatment with TUDCA but did not change after placebo therapy. In addition, therapy with TUDCA, but not placebo, increased muscle insulin signaling (phosphorylated insulin receptor substrate(Tyr) and Akt(Ser473) levels) (P < 0.05). Markers of ER stress in muscle or adipose tissue did not change after treatment with either TUDCA or placebo. This data demonstrate that TUDCA might be an effective pharmacological approach for treating insulin resistance. Additional studies are needed to evaluate the target cells and mechanisms responsible for this effect (4.)

Although that is the only credible study I can attribute positive results on those fronts, we can play “connect the dots” with some other pieces of literature such as the ones done on TUDCA supplementation in correlation to glucose metabolism. A study done in 2006 (5) linked endoplasmic reticulum stress to obesity, insulin resistance, and diabetes. They state” here, we provide evidence that this mechanistic link can be exploited for therapeutic purposes with orally active chemical chaperones. 4-Phenyl butyric acid and taurine-conjugated ursodeoxycholic acid alleviated ER stress in cells and whole animals. Treatment of obese and diabetic mice with these compounds resulted in normalization of hyperglycemia, restoration of systemic insulin sensitivity, resolution of fatty liver disease, and enhancement of insulin action in liver, muscle, and adipose tissues. Our results demonstrate that chemical chaperones enhance the adaptive capacity of the ER and act as potent antidiabetic modalities with potential application in the treatment of type 2 diabetes.” Another study along similar lines of endoplasmic reticulum stress and its correlation to insulin resistance looked at glucose-induced beta cell dysfunction in vivo in rats which showed a link between oxidative stress and endoplasmic reticulum stress. Healthy Wistar rats were infused i.v. with glucose for 48 h to achieve 20 mmol/l hyperglycaemia with or without the co-infusion of the superoxide dismutase mimetic tempol (TPO), or the chemical chaperones 4-phenylbutyrate (PBA) or tauroursodeoxycholic acid (TUDCA). This was followed by assessment of beta cell function and measurement of ER stress markers and superoxide in islets. Glucose infusion for 48 h increased mitochondrial superoxide and ER stress markers and impaired beta cell function. Co-infusion of TPO, which we previously found to reduce mitochondrial superoxide and prevent glucose-induced beta cell dysfunction, reduced ER stress markers. Similar to findings with TPO, co-infusion of PBA, which decreases mitochondrial superoxide, prevented glucose-induced beta cell dysfunction in isolated islets. TUDCA was also effective. Also similar to findings with TPO, PBA prevented beta cell dysfunction during hyperglycaemic clamps in vivo and after hyperglycaemia (15 mmol/l) for 96 h. Here, we causally implicate ER stress in hyperglycaemia-induced beta cell dysfunction in vivo. We show that: (1) there is a positive feedback cycle between oxidative stress and ER stress in glucose-induced beta cell dysfunction, which involves mitochondrial superoxide; and (2) this cycle can be interrupted by superoxide dismutase mimetics as well as chemical chaperones, which are of potential interest to preserve beta cell function in type 2 diabetes (6.)

I could continue on and on about the benefits of TUDCA! Heck, we didn’t even cover the fact that bile acids have the ability to induce energy expenditure by promoting intracellular thyroid hormone activation (7.) But, I do feel I’ve presented enough pertinent information to prove TUDCA has its place in everyone’s supplement regimen given the fact that it is a potent health and ergogenic aid that is more than affordable. In terms of practical application, there have been studies done showing improvements of liver regenesis rates at a dosage as low as 10mgs and other studies showing benefits for muscle tissue insulin sensitivity and for the treatment of liver disease as high as almost 2000mgs. In actual application I personally recommend my clients (that are competitive athletes) to supplement with 250mgs of TUDCA per day year round. Then, during periods of high stress such as a contest prep or anytime you’re truly pushing your “supplements”, upwards of 1000mgs per day. You will obviously need to get bloodwork done to see where your liver enzyme levels are and how they change at what specific dosage to know for sure (once again, thank you biological inter-individuality!) I have also included four more studies linked below in the reference section for your academic pleasure (8, 9, 10, 11.) Please read more and make the decision for yourself if TUDCA is something that could be beneficial in your everyday supplement stack.

References

  1. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. K D Setchell, C M Rodrigues, M Podda, A Crosignani. Gut. 1996 (https://www.ncbi.nlm.nih.gov/pubmed/8675100)
  2. Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. A. Larghi, A. Crosignani, P. M. Battezzati, G. De Valle, M. Allocca, P. Invernizzi, M. Zuin, M. Podda. Aliment Pharmacol Ther. 1997 (https://www.ncbi.nlm.nih.gov/pubmed/9146783)
  3. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study. A. Crosignani, P. M. Battezzati, K. D. Setchell, P. Invernizzi, G. Covini, M. Zuin, M. Podda. Dig Dis Sci. 1996 (https://www.ncbi.nlm.nih.gov/pubmed/8674405)
  4. Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women. Marleen Kars, Ling Yang, Margaret F. Gregor, B. Selma Mohammed, Terri A. Pietka, Brian N. Finck, Bruce W. Patterson, Jay D. Horton, Bettina Mittendorfer, Gökhan S. Hotamisligil, Samuel Klein. Diabetes. 2010 (https://www.ncbi.nlm.nih.gov/pubmed/20522594)
  5. Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes. Umut Özcan, Erkan Yilmaz, Lale Özcan, Masato Furuhashi, Eric Vaillancourt, Ross O. Smith, Cem Z. Görgün, Gökhan S. Hotamisligil. Science. Author manuscript; available in PMC 2016 Feb 4.. Published in final edited form as: Science. 2006 (https://www.ncbi.nlm.nih.gov/pubmed/16931765)
  6. Glucose-induced beta cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress. C. Tang, K. Koulajian, I. Schuiki, L. Zhang, T. Desai, A. Ivovic, P. Wang, C. Robson-Doucette, M. B. Wheeler, B. Minassian, et al. Diabetologia. 2012 (https://www.ncbi.nlm.nih.gov/pubmed/22396011)
  7. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Mitsuhiro Watanabe, Sander M. Houten, Chikage Mataki, Marcelo A. Christoffolete, Brian W. Kim, Hiroyuki Sato, Nadia Messaddeq, John W. Harney, Osamu Ezaki, Tatsuhiko Kodama, et al. Nature. 2006 (https://www.ncbi.nlm.nih.gov/pubmed/16400329)
  8. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. P. Invernizzi, K. D. Setchell, A. Crosignani, P. M. Battezzati, A. Larghi, N. C. O’Connell, M. Podda. Hepatology. 1999 (https://www.ncbi.nlm.nih.gov/pubmed/9918905)
  9. Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? C. Panella, E. Ierardi, M. F. De Marco, M. Barone, F. W. Guglielmi, L. Polimeno, A. Francavilla. Ital J Gastroenterol. 1995 (https://www.ncbi.nlm.nih.gov/pubmed/8541578)
  10. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects. U. Leuschner, S. Guldutuna, S. Bhatti, A. Elze, M. Imhof, T. You, G. Zimmer. Ital J Gastroenterol. 1995 (https://www.ncbi.nlm.nih.gov/pubmed/8563010)
  11. Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. G. Boden, J. Ruiz, C. J. Kim, X. Chen. Am J Physiol. 1996 (https://www.ncbi.nlm.nih.gov/pubmed/8779946)
]]>
A Lot More On HMB Part 1 https://redcon1online.com/hmb-part-1/ Thu, 11 May 2017 04:00:24 +0000 https://redcon1online.com/?p=3589 I previously wrote an article answering the very common question about HMB and is correlation to being as effective as anabolic steroids. But now that that simple question is answered, we can look further into HMB itself and the benefits it does offer and why I recommend it as a very potent ergogenic aid. HMB is a leucine metabolite. Roughly only 5% of leucine is actually oxidized into HMB. There are two supplement forms of HMB. Those being calcium HMB or as a free acid (which simply means its HMB without the calcium salt.) Between these two forms, we see that the free acid form of HMB is the superior option as it is more readily absorbed while simultaneously reaching a higher serum peak level (1.) Fuller et al looked at the free acid gel form of β-hydroxy-β-methylbutyrate and its clearance rates. Two studies were conducted and in each study four males and four females were given three treatments in a randomised, cross-over design. Treatments were CaHMB (gelatin capsule, 1 g), equivalent HMB free acid gel swallowed (FASW) and free acid gel held sublingual for 15 s then swallowed (FASL). Plasma HMB was measured for 3 h following treatment in study 1 and 24 h with urine collection in study 2. In both the studies, the times to peak plasma HMB were 128 (sem 11), 38 (sem 4) and 38 (sem 1) min (P < 0·0001) for CaHMB, FASW and FASL, respectively. The peak concentrations were 131 (sem 6), 249 (sem 14) and 239 (sem 14) μmol/l (P < 0·0001) for CaHMB, FASW and FASL, respectively. The areas under the curve were almost double for FASW and FASL (P < 0·0001). Daily urinary HMB excretion was not significantly increased resulting in more HMB retained (P < 0·003) with FASW and FASL. Half-lives were 3·17 (sem 0·22), 2·50 (sem 0·13) and 2·51 (sem 0·14) h for CaHMB, FASW and FASL, respectively (P < 0·004). Free acid gel resulted in quicker and greater plasma concentrations (+185%) and improved clearance (+25%) of HMB from plasma. In conclusion, HMB free acid gel could improve HMB availability and efficacy to tissues in health and disease.

HMB acts within the body very similarly to leucine meaning that they both inhibit muscle protein breakdown as well as increasing muscle protein synthesis. Maintenance of skeletal muscle mass is contingent upon the dynamic equilibrium (fasted losses-fed gains) in protein turnover. Of all nutrients, the single amino acid leucine (Leu) possesses the most marked anabolic characteristics in acting as a trigger element for the initiation of protein synthesis. While the mechanisms by which Leu is ‘sensed’ have been the subject of great scrutiny, as a branched-chain amino acid, Leu can be catabolized within muscle, thus posing the possibility that metabolites of Leu could be involved in mediating the anabolic effect(s) of Leu. Our objective was to measure muscle protein anabolism in response to Leu and its metabolite HMB. Using [1,2-(13)C2]Leu and [(2)H5]phenylalanine tracers, and GC-MS/GC-C-IRMS we studied the effect of HMB or Leu alone on MPS (by tracer incorporation into myofibrils), and for HMB we also measured muscle proteolysis (by arteriovenous (A-V) dilution). Orally consumed 3.42 g free-acid (FA-HMB) HMB (providing 2.42 g of pure HMB) exhibited rapid bioavailability in plasma and muscle and, similarly to 3.42 g Leu, stimulated muscle protein synthesis (MPS; HMB +70% vs. Leu +110%). While HMB and Leu both increased anabolic signalling (mechanistic target of rapamycin; mTOR), this was more pronounced with Leu (i.e. p70S6K1 signalling 90 min vs. 30 min for HMB). HMB consumption also attenuated muscle protein breakdown (MPB; -57%) in an insulin-independent manner. We conclude that exogenous HMB induces acute muscle anabolism (increased MPS and reduced MPB) albeit perhaps via distinct, and/or additional mechanism(s) to Leu (2.)

References

  1. Free acid gel form of β-hydroxy-β-methylbutyrate (HMB) improves HMB clearance from plasma in human subjects compared with the calcium HMB salt. John C. Fuller, Jr, Rick L. Sharp, Hector F. Angus, Shawn M. Baier, John A. Rathmacher. Br J Nutr. 2011 Feb; 105(3): 367–372. Published online 2010 Dec (https://www.ncbi.nlm.nih.gov/pubmed/21134325)
  2. Effects of leucine and its metabolite β-hydroxy-β-methylbutyrate on human skeletal muscle protein metabolism. D J Wilkinson, T Hossain, D S Hill, B E Phillips, H Crossland, J Williams, P Loughna, T A Churchward-Venne, L Breen, S M Phillips, T Etheridge, J A Rathmacher, K Smith, N J Szewczyk, P J Atherton. J Physiol. 2013 Jun 1; 591(Pt 11): 2911–2923. Published online 2013 Apr (https://www.ncbi.nlm.nih.gov/pubmed/23551944)
  3. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? M. E. Tischler, M. Desautels, A. L. Goldberg. J Biol Chem. 1982 Feb (https://www.ncbi.nlm.nih.gov/pubmed/6915936)
  4. Mechanism of attenuation by beta-hydroxy-beta-methylbutyrate of muscle protein degradation induced by lipopolysaccharide. Steven T. Russell, Michael J. Tisdale. Mol Cell Biochem. 2009 Oct; 330(1-2): 171–179. Published online 2009 Apr (https://www.ncbi.nlm.nih.gov/pubmed/19404720)
  5. Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Reut Kornasio, Ingo Riederer, Gillian Butler-Browne, Vincent Mouly, Zehava Uni, Orna Halevy. Biochim Biophys Acta. 2009 May; 1793(5): 755–763. Published online 2009 Jan (https://www.ncbi.nlm.nih.gov/pubmed/19211028)
  6. Effects of nine weeks of beta-hydroxy-beta- methylbutyrate supplementation on strength and body composition in resistance trained men. Jasmine S. Thomson, Patricia E. Watson, David S. Rowlands. J Strength Cond Res. 2009 May (https://www.ncbi.nlm.nih.gov/pubmed/19387396)
  7. The effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid supplementation on muscle mass, strength, and power in resistance-trained individuals: a randomized, double-blind, placebo-controlled study. Jacob M. Wilson, Ryan P. Lowery, Jordan M. Joy, J. C. Andersen, Stephanie M. C. Wilson, Jeffrey R. Stout, Nevine Duncan, John C. Fuller, Shawn M. Baier, Marshall A. Naimo, John Rathmacher. Eur J Appl Physiol. 2014 (https://www.ncbi.nlm.nih.gov/pubmed/24599749)
  8. The effect of HMB ingestion on the IGF-I and IGF binding protein response to high intensity military training. Redd et al. 2017. (http://www.growthhormoneigfresearch.com/article/S1096-6374(16)30061-2/fulltext)
  9. Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction. Barroso, M. C., Kramer, F., Greene, S. J., Scheyer, D., Köhler, T., Karoff, M., … Dinh, W. (2016). BMC Cardiovascular Disorders, 16, 199. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073807/)
  10. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways. Tania Benatar, Wenyi Yang, Yutaka Amemiya, Valentina Evdokimova, Harriette Kahn, Claire Holloway, Arun Seth. Breast Cancer Res Treat. 2012 (https://www.ncbi.nlm.nih.gov/pubmed/21997538)
  11. Insulin growth factor binding protein 7 is a novel target to treat dementia. Hope Y. Agbemenyah, Roberto C. Agis-Balboa, Susanne Burkhardt, Ivana Delalle, Andre Fischer. Neurobiol Dis. 2014 (https://www.ncbi.nlm.nih.gov/pubmed/24075854)
  12. Effect of β-hydroxy-β-methylbutyrate Supplementation During Energy Restriction in Female Judo Athletes. Wei Hung et al. Journal of Exercise Science & Fitness 2010. (http://www.sciencedirect.com/science/article/pii/S1728869X1060007X)
  13. Effects of Calcium β-HMB Supplementation During Training on Markers of Catabolism, Body Composition, Strength and Sprint Performance. Kreider et al. WAYNE STATE NUTRITION AND FOOD SCIENCE FACULTY RESEARCH PUBLICATIONS. 2013 (http://digitalcommons.wayne.edu/nfsfrp/7/)
]]>